Tetrazepam: Difference between revisions
m Protected "Tetrazepam": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +) |
||
| Line 20: | Line 20: | ||
{{SI}} | {{SI}} | ||
==Overview== | ==Overview== | ||
'''Tetrazepam''', (Clinoxan, Epsipam, Myolastan, Musaril, Relaxam, Spasmorelax) is a [[benzodiazepine]] derivative with [[anxiolytic]] and [[muscle relaxant]] properties. It is used mainly in Austria, France, Belgium and Germany to treat muscle spasm, anxiety disorders such as [[panic attacks]], or more rarely to treat [[clinical depression|depression]], [[premenstrual syndrome]] or [[agoraphobia]]. Tetrazepam has relatively little [[sedative]] effect at low doses while still producing useful muscle relaxation and anxiety relief. | '''Tetrazepam''', (Clinoxan, Epsipam, Myolastan, Musaril, Relaxam, Spasmorelax) is a [[benzodiazepine]] derivative with [[anxiolytic]] and [[muscle relaxant]] properties. It is used mainly in Austria, France, Belgium and Germany to treat muscle spasm, anxiety disorders such as [[panic attacks]], or more rarely to treat [[clinical depression|depression]], [[premenstrual syndrome]] or [[agoraphobia]]. Tetrazepam has relatively little [[sedative]] effect at low doses while still producing useful muscle relaxation and anxiety relief. | ||
| Line 37: | Line 37: | ||
[[ro:Tetrazepam]] | [[ro:Tetrazepam]] | ||
{{WH}} | {{WH}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 16:45, 20 August 2012
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code | |
| Pharmacokinetic data | |
| Elimination half-life | 15 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C16H17ClN2O |
| Molar mass | 288.772 |
|
WikiDoc Resources for Tetrazepam |
|
Articles |
|---|
|
Most recent articles on Tetrazepam |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Tetrazepam at Clinical Trials.gov Clinical Trials on Tetrazepam at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Tetrazepam
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Tetrazepam Discussion groups on Tetrazepam Patient Handouts on Tetrazepam Directions to Hospitals Treating Tetrazepam Risk calculators and risk factors for Tetrazepam
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Tetrazepam |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
Tetrazepam, (Clinoxan, Epsipam, Myolastan, Musaril, Relaxam, Spasmorelax) is a benzodiazepine derivative with anxiolytic and muscle relaxant properties. It is used mainly in Austria, France, Belgium and Germany to treat muscle spasm, anxiety disorders such as panic attacks, or more rarely to treat depression, premenstrual syndrome or agoraphobia. Tetrazepam has relatively little sedative effect at low doses while still producing useful muscle relaxation and anxiety relief.
The indicated adult dose for muscle spasm is 50 mg three to four times per day, increased if necessary to a maximum of 800mg per day, in divided doses. Tetrazepam is not generally recommended for use in children, except on the advice of a specialist.
Tetrazepam is only available in one strength and formulation, 50mg tablets. This dose is approximately equivalent to 5-7.5mg oral diazepam. Prolonged use, as with all benzodiazepines, should be avoided, as tolerance occurs and there is a risk of possible dependence and a benzodiazepine withdrawal syndrome after stopping or reducing dosage.
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Benzodiazepines